|
1
|
Sung H, Ferlay J, Siegel R, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. Feb 4–2021.(Online
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cidon EU, Ellis SG, Inam Y, Adeleke S,
Zarif S and Geldart T: Molecular targeted agents for gastric
cancer: A step forward towards personalized therapy. Cancers
(Basel). 5:64–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steeg PS: Metastasis suppressors alter the
signal transduction of cancer cells. Nat Rev Cancer. 3:55–63. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sanjo H, Kawai T and Akira S: DRAKs, novel
serine/threonine kinases related to death-associated protein kinase
that trigger apoptosis. J Biol Chem. 273:29066–29071. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bialik S and Kimchi A: The
death-associated protein kinases: Structure, function, and beyond.
Annu Rev Biochem. 75:189–210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao J, Liu D, Li J, Song Q and Wang Q:
Effect of STK17A on the sensitivity of ovarian cancer cells to
paclitaxel and carboplatin. Oncol Lett. 12:1107–1112. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mao P, Hever MP, Niemaszyk LM, Haghkerdar
JM, Yanco EG, Desai D, Beyrouthy MJ, Kerley-Hamilton JS, Freemantle
SJ and Spinella MJ: Serine/threonine kinase 17A is a novel p53
target gene and modulator of cisplatin toxicity and reactive oxygen
species in testicular cancer cells. J Biol Chem. 286:19381–19391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mao P, Hever-Jardine MP, Rahme GJ, Yang E,
Tam J, Kodali A, Biswal B, Fadul CE, Gaur A, Israel MA and Spinella
MJ: Serine/threonine kinase 17A is a novel candidate for
therapeutic targeting in glioblastoma. PLoS One. 8:e818032013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park Y, Kim W, Lee JM, Park J, Cho JK,
Pang K, Lee J, Kim D, Park SW, Yang KM and Kim SJ: Cytoplasmic
DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor
suppressor activity by binding to Smad3 to interrupt its complex
formation with Smad4. Oncogene. 34:5037–5045. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Short SP, Thompson JJ, Bilotta AJ, Chen X,
Revetta FL, Washington MK and Williams CS: Serine threonine kinase
17A maintains the epithelial state in colorectal cancer cells. Mol
Cancer Res. 17:882–894. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei W and Liu C: Prognostic and predictive
roles of microRNA-411 and its target STK17A in evaluating
radiotherapy efficacy and their effects on cell migration and
invasion via the p53 signaling pathway in cervical cancer. Mol Med
Rep. 21:267–281. 2020.PubMed/NCBI
|
|
12
|
Temmerman K, Simon B and Wilmanns M:
Structural and functional diversity in the activity and regulation
of DAPK-related protein kinases. FEBS J. 280:5533–5350. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang WJ, Kuo JC, Yao CC and Chen RH:
DAP-kinase induces apoptosis by suppressing integrin activity and
disrupting matrix survival signals. J Cell Biol. 159:169–179. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin Y, Hupp TR and Stevens C:
Death-associated protein kinase (DAPK) and signal transduction:
Additional roles beyond cell death. FEBS J. 277:48–57. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kiger AA, Baum B, Jones S, Jones MR,
Coulson A, Echeverri C and Perrimon N: A functional genomic
analysis of cell morphology using RNA interference. J Biol.
2:272003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Neubueser D and Hipfner DR: Overlapping
roles of Drosophila Drak and Rok kinases in epithelial
tissue morphogenesis. Mol Biol Cell. 21:2869–2879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Robertson F, Pinal N, Fichelson P and
Pichaud F: Atonal and EGFR signalling orchestrate rok- and
Drak-dependent adherens junction remodelling during ommatidia
morphogenesis. Development. 139:3432–3441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coleman ML, Sahai EA, Yeo M, Bosch M,
Dewar A and Olson MF: Membrane blebbing during apoptosis results
from caspase-mediated activation of ROCK I. Nat Cell Biol.
3:339–345. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gilmore AP: Anoikis. Cell Death Differ. 12
(Suppl 2):S1473–S1477. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang H, Liu YJ, Liu M and Li X:
Establishment and gene analysis of an oxaliplatin-resistant colon
cancer cell line THC8307/L-OHP. Anticancer Drugs. 18:633–639. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 7th edition.
New York NY: Springer; 2010
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Nie CJ, Hu L, Qin Y, Liu HB, Zeng
TT, Chen L, Fu L, Deng W, Chen SP, et al: Characterization of a
novel mechanism of genomic instability involving the
SEI1/SET/NM23H1 pathway in esophageal cancers. Cancer Res.
70:5695–5705. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inoue T, Umezawa A, Takenaka T, Suzuki H
and Okada H: The contribution of epithelial-mesenchymal transition
to renal fibrosis differs among kidney disease models. Kidney Int.
87:233–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen DH, Yu JW and Jiang BJ: Contactin 1:
A potential therapeutic target and biomarker in gastric cancer.
World J Gastroenterol. 21:9707–9716. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mesteri I, Schoppmann SF, Preusser M and
Birner P: Overexpression of CMET is associated with signal
transducer and activator of transcription 3 activation and
diminished prognosis in oesophageal adenocarcinoma but not in
squamous cell carcinoma. Eur J Cancer. 50:1354–1360. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thomas A, Mahantshetty U, Kannan S,
Deodhar K, Shrivastava SK, Kumar-Sinha C and Mulherkar R:
Expression profiling of cervical cancers in Indian women at
different stages to identify gene signatures during progression of
the disease. Cancer Med. 2:836–648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cekirge HS, Peynircioglu B and Saatci I:
Endovascular treatment of an ‘anterior cerebral artery’ aneurysm in
a patient with ‘embryonic unfused middle cerebral artery’ anomaly:
A case report. Neuroradiology. 47:690–694. 2005. View Article : Google Scholar : PubMed/NCBI
|
